BioSpace News Archive

Press Releases

Sanguina Announces Ruby: The Evolution of AnemoCheck Mobile’s Blood Health Platform

April 8, 2025
·
2 min read
Press Releases

Atalanta Therapeutics Publishes Preclinical Data Supporting Investigational RNAi Therapy for KCNT1-Related Epilepsy

April 8, 2025
·
3 min read
Press Releases

LifeMine Announces First Participant Dosed in First-in-human Phase 1 Clinical Trial of LIFE-001, Designed De Novo to Become a Field Dominating Immunosuppressive for Immune-mediated Disorders and Transplantation

April 8, 2025
·
4 min read
Press Releases

Merida Biosciences Launches with $121M to Create Therapeutics for Multiple Autoimmune and Allergic Diseases

April 8, 2025
·
4 min read
Press Releases

SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML

April 8, 2025
·
6 min read
Press Releases

Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product

April 8, 2025
·
9 min read
Press Releases

Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies

April 8, 2025
·
4 min read
Press Releases

City of Hope Study Demonstrates Proof of Concept for Targeted New Approach to Treat Pancreatic Cancer

April 8, 2025
·
5 min read
Press Releases

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

April 8, 2025
·
7 min read
Press Releases

Axsome Therapeutics to Report First Quarter 2025 Financial Results on May 5

April 8, 2025
·
4 min read